Heat shock proteins: the ‘Swiss Army Knife’ vaccines against cancers and infectious agents
- 21 March 2001
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 19 (17-19), 2590-2597
- https://doi.org/10.1016/s0264-410x(00)00492-8
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathwayInternational Immunology, 2000
- Identification of the Peptide-binding Site in the Heat Shock Chaperone/Tumor Rejection Antigen gp96 (Grp94)Online Journal of Public Health Informatics, 2000
- Structural Transitions Accompanying the Activation of Peptide Binding to the Endoplasmic Reticulum Hsp90 Chaperone GRP94Biochemistry, 1998
- Immunization with a Lymphocytic Choriomeningitis Virus Peptide Mixed with Heat Shock Protein 70 Results in Protective Antiviral Immunity and Specific Cytotoxic T LymphocytesThe Journal of Experimental Medicine, 1998
- Do human cancers express sharedprotectiveantigens? or The necessity of remembrance of things pastSeminars in Immunology, 1996
- Human tumor antigens recognized by T lymphocytes.The Journal of Experimental Medicine, 1996
- A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned PeptidesScience, 1995
- A unique tumor antigen produced by a single amino acid substitutionImmunity, 1995
- T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.The Journal of Experimental Medicine, 1994
- Individually distinct transplantation antigens of chemically induced mouse tumorsImmunology Today, 1988